highly significantp<0.001
Although the median age of cHL patients in the EBV+ group did not differ much from that of the EBV- cHL patient group (31 years, range: 4–74 ys and 27 years, range: 8–74 ys respectively) ( Table 1 ), the 10 years age group distribution between EBV+ and EBV- patients did show a highly significant difference (p<0.001).